Abstract
For advanced esophageal cancer, locoregional staging is best performed with EUS-FNA, with CT scan of the thorax and abdomen and FDG-PET, to detect metastatic disease. The role of EUS in restaging following neoadjuvant therapy remains controversial, with recent studies showing that FDG-PET/CT may be more accurate than EUS-FNA and CT scan for predicting nodal status and complete responders after neoadjuvant therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 530-534 |
Number of pages | 5 |
Journal | Current Opinion in Gastroenterology |
Volume | 24 |
Issue number | 4 |
DOIs | |
State | Published - Jul 2008 |
Keywords
- Esophageal cancer
- Restaging
- Staging
ASJC Scopus subject areas
- Gastroenterology